Navigation Links
Recent Study Demonstrates Anti-Inflammatory Properties of Oligonol® Lychee Fruit Polyphenols in Humans
Date:2/14/2011

PURCHASE, N.Y., Feb. 14, 2011 /PRNewswire/ -- A recently published study in Nutrition Research and Practice (Nutr Res Pract 2010;4(3):203-207) has verified the anti-inflammatory effects in humans of Oligonol® lychee fruit polyphenol.  The study examined Oligonol intake on cortisol and related cytokines in healthy young men.  Both cortisol and cytokine concentrations are inflammatory markers known to increase when stress such as exercise is caused on the body.  This study showed that oral intake of Oligonol had a significant effect on inhibiting cortisol and key inflammatory markers.

"Although a number of studies have demonstrated the anti-oxidant and anti-inflammatory properties of Oligonol, this is the first published trial in humans that confirms a important role for Oligonol as an anti-inflammatory agent," said Dr. Dan Kenner, a leading writer and consultant in alternative health care.

The study investigated Oligonol intake on cortisol, interleukin (IL)-1beta and IL-6 concentrations at rest and after physical exercise in nineteen healthy, sedentary males.  Each individual received water with 100 mg of Oligonol twice daily or a placebo for four weeks.  The body composition, the white blood cell and differential counts as well as the serum cortisol, interleukin (IL)-1beta and IL-6 concentration were measured before and after Oligonol intake.  The results showed that intake of Oligonol significantly decreased levels of cortisol and serum levels of IL-1beta and IL-6 compared to before treatment.  

Initiated four weeks prior in the first phase of the study, the individuals did not exercise but received the same dose of Oligonol or placebo.  Although not as significant, the results also demonstrated a reduction of the stress hormones cortisol and inflammatory cytokines (IL-1beta and IL-6).

"Flavanols from polyphenols are one of the most exciting and important topics in nutrition research in 2011, and results from this study provide further suggestions about the potential value of flavanol supplementation for health and human performance," said Dr. Robert Hackman, research professor at the University of California.

Oligonol is a unique, proprietary form of lychee fruit extract with significantly improved bioavailability due to its low-molecular weight polyphenols.  With a polyphenol concentration second only to strawberry, lychee fruit is a potent antioxidant that has proven beneficial for a number of health conditions. Clinical studies with Oligonol have demonstrated benefits for skin health through improving blood flow to the subdermal layer protecting it from damage caused by UV light and free radicals.  Other studies with Oligonol have shown improved cardiovascular function, reduction of visceral fat as well as reduction of exercise fatigue.  Oligonol has been successfully marketed in Japan as a functional ingredient for supplements, cosmetics and food.  Oligonol has been accepted as a "New Dietary Ingredient" by the FDA, received the prestigious Nutracon award as the Top Evidence-based New Ingredient of 2008 and has attained self-affirmed GRAS status.


'/>"/>
SOURCE Maypro Industries
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareCentrix to Present at Hospital Readmissions Conference
2. Rochester Medical Reports First Quarter Results and Recent Developments
3. Webcast Alert: Isis Pharmaceuticals Holds Webcast to Discuss Recent Advances in its Development Pipeline
4. European Neurologists Expect Significant Increases in the Use of Both Tysabri and Extavia in Their Multiple Sclerosis Patients the Next Six Months, According to a Recent Report From BioTrends
5. Recent NDRC Pricing Concessions Not Expected to Impact China Sky Ones Portfolio of Products
6. Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
7. Recent Patient Series Demonstrates Spirus Medicals Power Spiral Endoscope Enables Unprecedented Access to GI Tract
8. CareCentrix Appoints Chief Information Officer
9. Argos Therapeutics to Present Recent Clinical Developments and Corporate Overview at 18th Annual BioPartnering Europe
10. Lingohocken Fire Company Receives PAD Donation After Recent Rescue at Fox Heath Farm
11. Study of Brands Shows Tylenol Maintains Consumer Loyalty Despite Recent Quality Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
(Date:6/24/2016)... Gaithersburg, MD (PRWEB) , ... June 24, 2016 ... ... and protocols for human induced pluripotent stem (iPS) cells and other difficult to ... PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is ...
Breaking Medicine News(10 mins):